Dexlansoprazole for GORD Symptoms in GLP-1 RA Use
Obesity is a chronic, relapsing and multifactorial disease that affects approximately 650 million adults and 340 million children globally. GLP-1 RAs are increasingly prescribed for type 2 diabetes and weight
management in adults with overweight or obesity. Whilst these medications offer significant therapeutic benefits, gastrointestinal side effects, including acid reflux and heartburn, are commonly reported. Management includes eating smaller meals, avoiding trigger foods, remaining upright after eating and using antacids or proton pump inhibitors if needed.
